| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/16/2004 | EP1427740A1 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins rung |
| 06/16/2004 | EP1427721A1 Method for synthesis of 5-(3-pyridylmethylene)-imidazolidine-2,4-dione |
| 06/16/2004 | EP1427720A1 3-substituted-4-pyrimidone derivatives |
| 06/16/2004 | EP1427719A1 4-alkyl-substitute thienyloxy-pyridines |
| 06/16/2004 | EP1427709A1 3-substituted-4-pyrimidone derivatives |
| 06/16/2004 | EP1427708A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 06/16/2004 | EP1427707A1 Substituted indazole compounds for the treatment of inflammation |
| 06/16/2004 | EP1427705A2 Insecticidal diamides |
| 06/16/2004 | EP1427421A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents |
| 06/16/2004 | EP1427416A2 3-glyoxlylamideindoles for treating cancer |
| 06/16/2004 | EP1427415A1 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 06/16/2004 | EP1427413A2 2-aroylimidazole compounds for treating cancer |
| 06/16/2004 | EP1427408A2 CYCLIC HYDROXAMIC ACIDS AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-$g(a) CONVERTING ENZYME (TACE) |
| 06/16/2004 | EP1427379A2 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis |
| 06/16/2004 | EP1427326A2 Combination therapy for the treatment of cancer |
| 06/16/2004 | EP1351958B1 Imidazolo-5-yl-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 06/16/2004 | EP1282616B1 Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatement of pain |
| 06/16/2004 | EP1268469B1 N-(heterocyclyl)benzene or pyridine sulphonamides as antithrombotic agents and anticoagulants |
| 06/16/2004 | EP1265889B1 Medicaments against viral diseases |
| 06/16/2004 | EP1219173B1 Insecticides and acaricides |
| 06/16/2004 | EP1147083B1 Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| 06/16/2004 | EP0983243B1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
| 06/16/2004 | EP0979079B1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 06/16/2004 | EP0960104B1 N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3-one derivatives as factor xa inhibitors |
| 06/16/2004 | EP0897919B1 Novel pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents containing the same as the active ingredient |
| 06/16/2004 | EP0823423B1 1,4-disubstituted piperidine derivatives |
| 06/16/2004 | EP0815080B1 Di-substituted 1,4-piperidine esters and amides having 5-ht4 antagonistic activity |
| 06/16/2004 | EP0807105B1 Pyridopyrimidones, quinolines and fused n-heretocycles as bradykinin antagonists |
| 06/16/2004 | CN1505628A Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 06/16/2004 | CN1505626A Novel benzylpiperidine compound |
| 06/16/2004 | CN1505625A Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| 06/16/2004 | CN1505624A Piperazino-derivatives and their use as pde4 inhibitor |
| 06/16/2004 | CN1505613A Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppar-gamma binding agents |
| 06/16/2004 | CN1505607A Peptide-deformylase inhibitors |
| 06/16/2004 | CN1505514A Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors |
| 06/16/2004 | CN1504462A Pyrimidinyl derivatives as interleukin inhibitors |
| 06/16/2004 | CN1153770C Substitued nitrogen heterocyclic ring as inhibitors of P38 protein kinase |
| 06/16/2004 | CN1153766C Nitroketone compound, its preparing process and pharmaceutical composition containing same |
| 06/16/2004 | CN1153765C 4-aryl-1-phenylalkyl-1,2,3,6-Tetrahydropyridines having neurotrophic and neuroprotective activity |
| 06/15/2004 | US6750350 Therapy for sexual disorders |
| 06/15/2004 | US6750349 Superior gastrokinetic properties |
| 06/15/2004 | US6750348 Protective effects against infection by hiv through binding to chemokine receptors, including cxcr4 and ccr5;n-(2-pyridinylmethyl)-n'-(2-(phenylureido)ethyl)-n'-(5,6,7,8-tetrahydro-8-quinolinyl)-1,4-benzenedimethanamine |
| 06/15/2004 | US6750342 Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade |
| 06/15/2004 | US6750338 Process for making 5-substituted pyrazoles |
| 06/15/2004 | US6750241 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic |
| 06/15/2004 | US6750238 Aralkyl ester soft drugs |
| 06/15/2004 | US6750233 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 06/15/2004 | US6750232 2-aminopyridine compounds and use thereof as drugs |
| 06/15/2004 | US6750231 Skin disorders; gastrointestinal disorders |
| 06/15/2004 | US6750230 Pyrazole derivatives |
| 06/15/2004 | US6750228 Uncontrolled breakdown of connective tissue by metalloproteases is a feature of many pathological conditions |
| 06/15/2004 | US6750222 Substituted phenyl derivatives |
| 06/15/2004 | US6750218 Inhibitory activity on phosphorylation of platelet-derived growth factor (pdgf) receptor useful for the treatment of cell-proliferative diseases such as arteriosclerosis, vascular reobstruction, cancer and glomerulosclerosis |
| 06/15/2004 | US6750214 Quinoline and quinazoline compounds useful in therapy |
| 06/15/2004 | US6749864 Stabilized pharmaceutical composition |
| 06/10/2004 | WO2004048922A2 Bead-based detection of ligand-gpcr-g protein complexes |
| 06/10/2004 | WO2004048375A1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same |
| 06/10/2004 | WO2004048367A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 06/10/2004 | WO2004048366A1 2-oxoindoline derivatives |
| 06/10/2004 | WO2004048365A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 06/10/2004 | WO2004048364A1 2-[(4-benzyl)-1-piperidinyl)methyl]benzimidazole-5-ol derivatives as nr2b receptor antagonists |
| 06/10/2004 | WO2004048363A1 Imidazole derivative, process for producing the same, and use |
| 06/10/2004 | WO2004048352A2 2-cyanopyrrolidines and their analogues as dpp-iv inhibitors |
| 06/10/2004 | WO2004048345A2 2,5-diketopiperazines for the treatment of obesity |
| 06/10/2004 | WO2004048344A1 Compositions containing pyrimidine derivatives as inhibitors of cox-2 |
| 06/10/2004 | WO2004048343A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 06/10/2004 | WO2004048339A1 Isoquinoline compounds and medicinal use thereof |
| 06/10/2004 | WO2004048334A1 Phenyl substituted piperidine compounds for use as ppar activators |
| 06/10/2004 | WO2004048333A1 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 06/10/2004 | WO2004048332A1 Isoindoline derivative |
| 06/10/2004 | WO2004048330A1 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 06/10/2004 | WO2004048322A1 Cannabinoid receptor ligands |
| 06/10/2004 | WO2004047840A1 Derivatives of pyridinalkyl-amonoalkyl-1h-indole inhibiting receptors 5-ht and recapture of serotonin which can be used as antidepressant and anxiolitic |
| 06/10/2004 | WO2004047781A1 N-aryl-4,5-diaminopyrazols and dyes containing said compounds |
| 06/10/2004 | WO2004047769A2 Benzimidazoles and analogs thereof as antibacterials |
| 06/10/2004 | WO2004047745A2 3-(pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openers |
| 06/10/2004 | WO2004047744A2 3-heterocyclic benzylamide derivatives as potassium channel openers |
| 06/10/2004 | WO2004032834A3 Thrombin inhibitors |
| 06/10/2004 | WO2004030620A3 Novel tyrosine kinase inhibitors |
| 06/10/2004 | WO2004009543A8 1-carbonyl-4-cyano-pyrrolidine-2-carboxylic acid derivatives as hepatitis c virus inhibitors |
| 06/10/2004 | WO2004002982A3 A process for preparation of optically pure or optically enriched sulfoxide compounds, including amorphous esomeprazole and salts thereof |
| 06/10/2004 | WO2003066005A3 Ansamycins having improved pharmacological and biological properties |
| 06/10/2004 | WO2003059265A3 Compositions and methods for treating heart failure |
| 06/10/2004 | WO2003033490A9 Synthesis of 4-[(z)-(4-bromophenyl)(ethoxyimino)methyl]-1'-[2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'methyl-1,4'bipiperidine |
| 06/10/2004 | US20040110956 Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 06/10/2004 | US20040110952 e.g., N-[1-(3-phenyl-3-[cyclopenytlacetylamino]propyl)-4-piperidinyl]-N-ethyl-4-methanesulfonylphenylacetamide |
| 06/10/2004 | US20040110945 Very Late Antigen (Vla-4); such as 4-((4S)-fluoro-1-(2-phenylamino-6-benzoxazolylacetyl)-(2S)-pyrrolidinylmethoxy)benzoic acid; for treatment of inflammatory diseases, autoimmune diseases, metastasis, bronchial asthma, rhinostenosis, and diabetes |
| 06/10/2004 | US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 06/10/2004 | US20040110816 hetercyclyloxy-substituted; e.g., 5-[3-Ethyl-1-methyl-5-(pyridin-2-yloxy)-1H-pyrazol4-yloxy]-isophthalonitrile; reverse transcriptase inhibitors; treating Acquired Immune Deficiency Syndrome |
| 06/10/2004 | US20040110815 e.g., 7-(2,4-Dichloro-phenyl)-2-methyl-3-(1-propyl-but-1-enyl)-2H-indazole hydrochloride; treating phobias; stress-related illnesses; mood, eating, and generalized anxiety disorders; stress-induced gastrointestinal dysfunctions, etc. |
| 06/10/2004 | US20040110809 di- and tricycle-substituted imidazolidine-, oxazolidine- and thiazolidine diones and thiones, e.g., 5-[p-(quinolin-3-yl)-alpha-hydroxybenzyl]-5-methylimidazolidinedione |
| 06/10/2004 | US20040110808 Acylamino-substituted heteroaromatic compounds and their use as pharmaceuticals |
| 06/10/2004 | US20040110805 Sulfur compounds such as 4-[(4-{3-[(2-adamantylamino)sulfonyl]propoxy}phenyl)sulfonyl]- N-hydroxytetrahydro-2H-pyran-4-carboximide, used as antagonists for metalloenzyme and/or aggrecanase activity; tissue repair |
| 06/10/2004 | US20040110804 4-hydroxy-5-oxo-1-(2-[4-methylpiperazin-1-yl]ethyl)-2,5-dihydro-1H-pyrrole-3-carboxylic acid (3,4-dichlorobenzyl)-methyl-amide for human immunodeficiency virus (HIV) treatment |
| 06/10/2004 | US20040110802 Antibacterial benzoic acid derivatives |
| 06/10/2004 | US20040110798 A pyridyl-2yl-4-[1,2,3-triazole] derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders |
| 06/10/2004 | US20040110793 Heterocyclo inhibitors of potassium channel function |
| 06/10/2004 | US20040110780 A cyclopenta[d]pyrimidine, or 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine derivatives; treating metabolic disorders, type II diabetes, controlling glucose levels |
| 06/10/2004 | US20040110779 Hydantoin derivsatives with affinity for somatostatin receptors |
| 06/10/2004 | US20040110770 Cyclin-dependent kinases (CDK); Cdc2/cyclin B (CDK-1) enzymatic complex; 1,3-dihydro-3-(imidazol-4-ylmethylene)-5-(pyrid-3-yl)-2H-indolin-2-one for example; antitumor agent |